http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110187100-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate | 2019-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110187100-B |
| titleOfInvention | Application of Prokineticin2 in preparation of sepsis diagnostic reagent and treatment medicine |
| abstract | The invention provides application of Prokineticin2(PK2) in preparing sepsis diagnostic reagents and therapeutic drugs. The invention aims to provide a brand-new diagnosis marker and a treatment target for the diagnosis and treatment of the sepsis and provide a new scheme for the diagnosis and treatment of the sepsis. On one hand, the application value of PK2 in sepsis prediction, diagnosis, disease monitoring and prognosis judgment is determined by evaluating the sensitivity, specificity, area under ROC curve and other statistical analysis methods of Prokineticin2(PK2) in sepsis diagnosis; on the other hand, the application value of Prokineticin2(PK2) in treating sepsis is preliminarily determined through animal experiment survival rate, organ injury detection and the like. |
| priorityDate | 2019-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 120.